234 related articles for article (PubMed ID: 26519739)
1. Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor.
Takano K; Kinoshita M; Takagaki M; Sakai M; Tateishi S; Achiha T; Hirayama R; Nishino K; Uchida J; Kumagai T; Okami J; Kawaguchi A; Hashimoto N; Nakanishi K; Imamura F; Higashiyama M; Yoshimine T
Neuro Oncol; 2016 May; 18(5):716-24. PubMed ID: 26519739
[TBL] [Abstract][Full Text] [Related]
2. CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung.
Ozkan E; West A; Dedelow JA; Chu BF; Zhao W; Yildiz VO; Otterson GA; Shilo K; Ghosh S; King M; White RD; Erdal BS
AJR Am J Roentgenol; 2015 Nov; 205(5):1016-25. PubMed ID: 26496549
[TBL] [Abstract][Full Text] [Related]
3. Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.
Kaneda T; Yoshioka H; Tamiya M; Tamiya A; Hata A; Okada A; Niwa T; Shiroyama T; Kanazu M; Ishida T; Katakami N
BMC Cancer; 2018 Jan; 18(1):6. PubMed ID: 29291705
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors.
Lin CC; Hsu HH; Sun CT; Shih JY; Lin ZZ; Yu CJ; Chen GG; Hsin MK; Lam KC; Leung L; Yang CH; Mok T
J Thorac Oncol; 2010 Sep; 5(9):1424-9. PubMed ID: 20631634
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer.
Daniele L; Cassoni P; Bacillo E; Cappia S; Righi L; Volante M; Tondat F; Inghirami G; Sapino A; Scagliotti GV; Papotti M; Novello S
J Thorac Oncol; 2009 Jun; 4(6):684-8. PubMed ID: 19404216
[TBL] [Abstract][Full Text] [Related]
6. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
Park J; Kobayashi Y; Urayama KY; Yamaura H; Yatabe Y; Hida T
PLoS One; 2016; 11(8):e0161081. PubMed ID: 27518729
[TBL] [Abstract][Full Text] [Related]
7. Advanced lung adenocarcinoma harboring a mutation of the epidermal growth factor receptor: CT findings after tyrosine kinase inhibitor therapy.
Choi CM; Kim MY; Lee JC; Kim HJ
Radiology; 2014 Feb; 270(2):574-82. PubMed ID: 24086072
[TBL] [Abstract][Full Text] [Related]
8. [Impacts of EGFR 19 exon mutations on brain metastases in treatment-naïve patients with lung adenocarcinoma].
Wang WL; Li HW; Cao JZ; Zhang XQ; Song X; Jia SF; Jia HX
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):744-748. PubMed ID: 29061017
[No Abstract] [Full Text] [Related]
9. Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.
Das BR; Bhaumik S; Ahmad F; Mandsaurwala A; Satam H
Pathol Oncol Res; 2015 Jul; 21(3):675-87. PubMed ID: 25637496
[TBL] [Abstract][Full Text] [Related]
10. Total regression of brain metastases in non-small cell lung cancer patients harboring EGFR mutations treated with gefitinib without radiotherapy: two case reports.
Chonan M; Narita N; Tominaga T
BMC Res Notes; 2016 Jan; 9():2. PubMed ID: 26724810
[TBL] [Abstract][Full Text] [Related]
11. Relationships between EGFR mutation status of lung cancer and preoperative factors - are they predictive?
Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Taniguchi M; Tonami H; Ueda Y; Sakuma T
Asian Pac J Cancer Prev; 2014; 15(2):657-62. PubMed ID: 24568474
[TBL] [Abstract][Full Text] [Related]
12. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
[TBL] [Abstract][Full Text] [Related]
13. EGFR mutation and brain metastasis in pulmonary adenocarcinomas.
Shin DY; Na II; Kim CH; Park S; Baek H; Yang SH
J Thorac Oncol; 2014 Feb; 9(2):195-9. PubMed ID: 24419416
[TBL] [Abstract][Full Text] [Related]
14. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
[TBL] [Abstract][Full Text] [Related]
15. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features.
Sekine A; Kato T; Hagiwara E; Shinohara T; Komagata T; Iwasawa T; Satoh H; Tamura K; Kasamatsu T; Hayashihara K; Saito T; Takahashi H; Ogura T
Lung Cancer; 2012 Jul; 77(1):64-9. PubMed ID: 22335887
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
Hsu KH; Chen KC; Yang TY; Yeh YC; Chou TY; Chen HY; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Chang GC; Chen CJ; Yang PC
J Thorac Oncol; 2011 Jun; 6(6):1066-72. PubMed ID: 21512404
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI).
Tseng YH; Hung HY; Sung YC; Tseng YC; Lee YC; Whang-Peng J; Chen YM
J Chemother; 2016; 28(1):50-8. PubMed ID: 25976428
[TBL] [Abstract][Full Text] [Related]
18. Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer.
Lee VH; Tin VP; Choy TS; Lam KO; Choi CW; Chung LP; Tsang JW; Ho PP; Leung DK; Ma ES; Liu J; Shek TW; Kwong DL; Leung TW; Wong MP
J Thorac Oncol; 2013 Sep; 8(9):1148-55. PubMed ID: 23945384
[TBL] [Abstract][Full Text] [Related]
19. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
[TBL] [Abstract][Full Text] [Related]
20. CT Features of Epidermal Growth Factor Receptor-Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma.
Hasegawa M; Sakai F; Ishikawa R; Kimura F; Ishida H; Kobayashi K
J Thorac Oncol; 2016 Jun; 11(6):819-26. PubMed ID: 26917231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]